Ethoxyfagaronine, a synthetic analogue of fagaronine that inhibits vascular endothelial growth factor-1, as a new anti-angiogeneic agent
详细信息 查看全文
- 作者：Farid Ouchani (1)
Albin Jeanne (1)
Jessica Thevenard (1)
Jean-Jacques Helesbeux (2)
Amandine Wahart (1)
Isabelle Letinois (1)
Olivier Duval (2)
Laurent Martiny (1)
Emmanuelle Charpentier (1)
J茅r么me Devy (1) - 关键词：Ethoxyfagaronine ; Angiogenesis ; VEGF receptor ; FAK ; MT1 ; MMP
- 刊名：Investigational New Drugs
- 出版年：2015
- 出版时间：February 2015
- 年：2015
- 卷：33
- 期：1
- 页码：75-85
- 全文大小：9,020 KB
- 参考文献：1. Shibuya M (2006) Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis. Angiogenesis 9:225鈥?30, discussion 31 CrossRef
2. Shibuya M (2014) VEGF-VEGFR signals in health and disease. Biomol Ther (Seoul) 22:1鈥? CrossRef
3. Cross MJ, Dixelius J, Matsumoto T, Claesson-Welsh L (2003) VEGF-receptor signal transduction. Trends Biochem Sci 28:488鈥?94 CrossRef
4. Kampen KR, Ter Elst A, de Bont ES (2013) Vascular endothelial growth factor signaling in acute myeloid leukemia. Cell Mol Life Sci 70:1307鈥?317 CrossRef
5. Podar K, Anderson KC (2005) The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications. Blood 105:1383鈥?395 CrossRef
6. Podar K, Anderson KC (2010) A therapeutic role for targeting c-Myc/Hif-1-dependent signaling pathways. Cell Cycle 9:1722鈥?728 CrossRef
7. Medinger M, Mross K (2010) Clinical trials with anti-angiogenic agents in hematological malignancies. J Angiogenes Res 2:10 CrossRef
8. Lucas DM, Still PC, Perez LB, Grever MR, Kinghorn AD (2010) Potential of plant-derived natural products in the treatment of leukemia and lymphoma. Curr Drug Targets 11:812鈥?22 CrossRef
9. Basini G, Bussolati S, Santini SE, Grasselli F (2009) Stanniocalcin, a potential ovarian angiogenesis regulator, does not affect endothelial cell apoptosis. Ann N Y Acad Sci 1171:94鈥?9 CrossRef
10. Eun JP, Koh GY (2004) Suppression of angiogenesis by the plant alkaloid, sanguinarine. Biochem Biophys Res Commun 317:618鈥?24 CrossRef
11. De Stefano I, Raspaglio G, Zannoni GF, Travaglia D, Prisco MG, Mosca M et al (2009) Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma. Biochem Pharmacol 78:1374鈥?381 CrossRef
12. Messmer WM, Tin-Wa M, Fong HH, Bevelle C, Farnsworth NR, Abraham DJ et al (1972) Fagaronine, a new tumor inhibitor isolated from Fagara zanthoxyloides Lam. (Rutaceae). J Pharm Sci 61:1858鈥?859 CrossRef
13. Comoe L, Jeannesson P, Trentesaux C, Desoize B, Jardillier JC (1987) The antileukemic alkaloid fagaronine and the human K 562 leukemic cells: effects on growth and induction of erythroid differentiation. Leuk Res 11:445鈥?51 CrossRef
14. Stermitz FR, Larson KA, Kim DK (1973) Some structural relationships among cytotoxic and antitumor benzophenanthridine alkaloid derivatives. J Med Chem 16:939鈥?40 CrossRef
15. Lynch MA, Duval O, Sukhanova A, Devy J, MacKay SP, Waigh RD et al (2001) Synthesis, biological activity and comparative analysis of DNA binding affinities and human DNA topoisomerase I inhibitory activities of novel 12-alkoxy-benzo[c]phenanthridinium salts. Bioorg Med Chem Lett 11:2643鈥?646 CrossRef
16. Deroussent A, Re M, Hoellinger H, Vanquelef E, Duval O, Sonnier M et al (2004) In vitro metabolism of ethoxidine by human CYP1A1 and rat microsomes: identification of metabolites by high-performance liquid chromatography combined with electrospray tandem mass spectrometry and accurate mass measurements by time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 18:474鈥?82 CrossRef
17. Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ et al (2010) Guidelines for the welfare and use of animals in cancer research. Br J Cancer 102:1555鈥?577 CrossRef
18. Ouchani F, Devy J, Rusciani A, Helesbeux JJ, Salesse S, Letinois I et al (2012) Targeting focal adhesion assembly by ethoxyfagaronine prevents lymphoblastic cell adhesion to fibronectin. Anal Cell Pathol 35:267鈥?84 CrossRef
19. Abu-Ghazaleh R, Kabir J, Jia H, Lobo M, Zachary I (2001) Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells. Biochem J 360:255鈥?64 CrossRef
20. Galvez BG, Matias-Roman S, Albar JP, Sanchez-Madrid F, Arroyo AG (2001) Membrane type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling. J Biol Chem 276:37491鈥?7500 CrossRef
21. Medinger M, Fischer N, Tzankov A (2010) Vascular endothelial growth factor-related pathways in hemato-lymphoid malignancies. J Oncol 2010:729725 CrossRef
22. Sallam TH, El Telbany MA, Mahmoud HM, Iskander MA (2013) Significance of neuropilin-1 expression in acute myeloid leukemia. Turk J Haematol 30:300鈥?06 CrossRef
23. Ma J, Waxman DJ (2008) Combination of antiangiogenesis with chemotherapy for more effective cancer treatment. Mol Cancer Ther 7:3670鈥?684 CrossRef
24. Thevenard J, Ramont L, Devy J, Brassart B, Dupont-Deshorgue A, Floquet N et al (2010) The YSNSG cyclopeptide derived from tumstatin inhibits tumor angiogenesis by down-regulating endothelial cell migration. Int J Cancer J Int Du Cancer 126:1055鈥?066
25. Genis L, Galvez BG, Gonzalo P, Arroyo AG (2006) MT1-MMP: universal or particular player in angiogenesis? Cancer Metastasis Rev 25:77鈥?6 CrossRef
26. Lauffenburger DA, Horwitz AF (1996) Cell migration: a physically integrated molecular process. Cell 84:359鈥?69 CrossRef
27. Parat MO, Anand-Apte B, Fox PL (2003) Differential caveolin-1 polarization in endothelial cells during migration in two and three dimensions. Mol Biol Cell 14:3156鈥?168 CrossRef
28. Tahir SA, Park S, Thompson TC (2009) Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells. Cancer Biol Ther 8:2286鈥?296 CrossRef
29. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z (1999) Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9鈥?2
30. Devy J, Ouchani F, Oudot C, Helesbeux JJ, Vanquelef E, Salesse S, et al (2010). The anti-invasive activity of synthetic alkaloid ethoxyfagaronine on L1210 leukemia cells is mediated by down-regulation of plasminogen activators and MT1-MMP expression and activity. Invest New Drugs - 作者单位：Farid Ouchani (1)
Albin Jeanne (1)
Jessica Thevenard (1)
Jean-Jacques Helesbeux (2)
Amandine Wahart (1)
Isabelle Letinois (1)
Olivier Duval (2)
Laurent Martiny (1)
Emmanuelle Charpentier (1)
J茅r么me Devy (1)
1. CNRS UMR7369 MEDyC, Laboratoire SiRMa, SFR CAP-Sant茅, Universit茅 de Reims Champagne-Ardenne, Moulin de la Housse, BP 1039, 51687, Reims cedex 2, France
2. SONAS, UFR Sciences Pharmaceutiques et Ing茅nierie de la Sant茅, Universit茅 d鈥橝ngers, SFR QUASAV 4207, 16 bd Daviers, 49100, Angers, France - 刊物类别：Medicine
- 刊物主题：Medicine & Public Health
Oncology
Pharmacology and Toxicology - 出版者：Springer Netherlands
- ISSN：1573-0646
文摘